Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 17, 2012
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus
Hiroaki Uchida, Marco Marzulli, Kenji Nakano, et al.
Nature Communications
|
June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma
Eleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
Jennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells
Mark A Currier, Francis K Eshun, Allyson Sholl, et al.
Molecular Therapy. Oncology
|
May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Human Gene Therapy
|
April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013
Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 17, 2012
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus
Hiroaki Uchida, Marco Marzulli, Kenji Nakano, et al.
Nature Communications
|
June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma
Eleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
Jennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells
Mark A Currier, Francis K Eshun, Allyson Sholl, et al.
Molecular Therapy. Oncology
|
May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Human Gene Therapy
|
April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013
Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Page
of 8